MXPA04007030A - Metodo de tratamiento de un paciente que requiere analgesia. - Google Patents
Metodo de tratamiento de un paciente que requiere analgesia.Info
- Publication number
- MXPA04007030A MXPA04007030A MXPA04007030A MXPA04007030A MXPA04007030A MX PA04007030 A MXPA04007030 A MX PA04007030A MX PA04007030 A MXPA04007030 A MX PA04007030A MX PA04007030 A MXPA04007030 A MX PA04007030A MX PA04007030 A MXPA04007030 A MX PA04007030A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- patient requiring
- analgesia
- devazepide
- requiring analgesia
- Prior art date
Links
- 230000036592 analgesia Effects 0.000 title abstract 3
- KAEHGTRAXGGNBL-HSZRJFAPSA-N devazepide Chemical compound O=C([C@@H](NC(=O)C=1N=C2[CH]C=CC=C2C=1)N=1)N(C)C2=CC=CC=C2C=1C1=CC=CC=C1 KAEHGTRAXGGNBL-HSZRJFAPSA-N 0.000 abstract 2
- 229950007317 devazepide Drugs 0.000 abstract 2
- 239000000014 opioid analgesic Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000008180 pharmaceutical surfactant Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Laser Surgery Devices (AREA)
- Plural Heterocyclic Compounds (AREA)
- Electrotherapy Devices (AREA)
- Confectionery (AREA)
- Radiation-Therapy Devices (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201367.0A GB0201367D0 (en) | 2002-01-22 | 2002-01-22 | Composition |
| PCT/GB2003/000221 WO2003061632A1 (en) | 2002-01-22 | 2003-01-22 | Method of treatment of a patient requiring analgesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04007030A true MXPA04007030A (es) | 2004-10-11 |
Family
ID=9929492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04007030A MXPA04007030A (es) | 2002-01-22 | 2003-01-22 | Metodo de tratamiento de un paciente que requiere analgesia. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1467718B1 (https=) |
| JP (1) | JP2005521655A (https=) |
| AT (1) | ATE310509T1 (https=) |
| BR (1) | BR0307022A (https=) |
| CA (1) | CA2473884A1 (https=) |
| DE (1) | DE60302431T2 (https=) |
| ES (1) | ES2253662T3 (https=) |
| GB (1) | GB0201367D0 (https=) |
| IL (1) | IL162768A0 (https=) |
| MX (1) | MXPA04007030A (https=) |
| NO (1) | NO20042758L (https=) |
| PL (1) | PL371523A1 (https=) |
| WO (1) | WO2003061632A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0213198D0 (en) * | 2002-06-10 | 2002-07-17 | Ml Lab Plc | Method of treatment |
| GB0406280D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Chemical compounds |
| BRPI0520554A2 (pt) | 2005-09-19 | 2009-06-13 | Arrow Therapeutics Ltd | uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica |
| WO2008051889A1 (en) * | 2006-10-24 | 2008-05-02 | The Johns Hopkins University | Rapid release mini-tablets provide analgesia in laboratory animals |
| EP2197448A4 (en) * | 2007-09-12 | 2010-11-17 | Elan Pharma Int Ltd | dosing schedule |
| EP2611445B1 (en) * | 2010-09-03 | 2018-08-15 | Zoetis Belgium S.A. | High dose buprenorphine compositions and use as analgesic |
| US20120171277A1 (en) * | 2011-01-03 | 2012-07-05 | Royds Robert B | Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist |
| US10729687B1 (en) | 2019-07-09 | 2020-08-04 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| US10653690B1 (en) | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| RS63725B1 (sr) | 2020-05-18 | 2022-12-30 | Orexo Ab | Nova farmaceutska kompozicija za davanje leka |
| GB202117016D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical device |
| AR127780A1 (es) | 2021-11-25 | 2024-02-28 | Orexo Ab | Nueva composición farmacéutica que comprende adrenalina |
| US12090151B1 (en) | 2023-05-12 | 2024-09-17 | Michael Guarnieri | Injectable sustained release buprenorphine formulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1564039A (en) * | 1976-12-09 | 1980-04-02 | Berger F | Analgesic compositions comprising dextropropoxyphene and benzodiazepines |
| US5153191A (en) * | 1991-08-20 | 1992-10-06 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
| GB9721746D0 (en) * | 1997-10-15 | 1997-12-10 | Panos Therapeutics Limited | Compositions |
-
2002
- 2002-01-22 GB GBGB0201367.0A patent/GB0201367D0/en not_active Ceased
-
2003
- 2003-01-22 EP EP03708305A patent/EP1467718B1/en not_active Expired - Lifetime
- 2003-01-22 MX MXPA04007030A patent/MXPA04007030A/es not_active Application Discontinuation
- 2003-01-22 ES ES03708305T patent/ES2253662T3/es not_active Expired - Lifetime
- 2003-01-22 BR BR0307022-0A patent/BR0307022A/pt not_active IP Right Cessation
- 2003-01-22 JP JP2003561577A patent/JP2005521655A/ja not_active Withdrawn
- 2003-01-22 IL IL16276803A patent/IL162768A0/xx unknown
- 2003-01-22 AT AT03708305T patent/ATE310509T1/de not_active IP Right Cessation
- 2003-01-22 PL PL03371523A patent/PL371523A1/xx not_active Application Discontinuation
- 2003-01-22 CA CA002473884A patent/CA2473884A1/en not_active Abandoned
- 2003-01-22 DE DE60302431T patent/DE60302431T2/de not_active Expired - Fee Related
- 2003-01-22 WO PCT/GB2003/000221 patent/WO2003061632A1/en not_active Ceased
-
2004
- 2004-06-30 NO NO20042758A patent/NO20042758L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE310509T1 (de) | 2005-12-15 |
| WO2003061632A1 (en) | 2003-07-31 |
| GB0201367D0 (en) | 2002-03-13 |
| CA2473884A1 (en) | 2003-07-31 |
| IL162768A0 (en) | 2005-11-20 |
| NO20042758L (no) | 2004-09-22 |
| EP1467718A1 (en) | 2004-10-20 |
| BR0307022A (pt) | 2004-11-03 |
| EP1467718B1 (en) | 2005-11-23 |
| DE60302431D1 (de) | 2005-12-29 |
| PL371523A1 (en) | 2005-06-27 |
| DE60302431T2 (de) | 2006-07-27 |
| JP2005521655A (ja) | 2005-07-21 |
| ES2253662T3 (es) | 2006-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| WO2000021515A3 (en) | Intranasal codeine for the rapid suppression of cough and rapid relief of pain | |
| WO2003080022A3 (en) | Analgesics for nasal administration | |
| NZ508526A (en) | Opioid formulations for treating pain | |
| AUPN603895A0 (en) | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids | |
| AU3898700A (en) | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages | |
| WO2004000354A3 (en) | Method of treating the syndrome of lipodystrophy | |
| NZ513304A (en) | Combinations of formoterol and a tiotropium salt | |
| IL160222A0 (en) | Opioid agonist formulations with releasable and sequestered antagonist | |
| PL312219A1 (en) | Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids | |
| UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
| AP2004003157A0 (en) | Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease | |
| GB0201367D0 (en) | Composition | |
| RO116771B1 (ro) | Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine | |
| GB0020504D0 (en) | Therapeutic method | |
| WO2002065989A3 (en) | Aminoglycoside treatment for lysosomal storage diseases | |
| WO2001045715A3 (en) | Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain | |
| SE9902597D0 (sv) | New use | |
| TW200503683A (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| EP0799618A3 (en) | Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer | |
| EP0906757A3 (en) | Analgesic composition comprising moxonidine and an opioid analgesic agent | |
| IL166596A0 (en) | Salt of morphine-6-glucoronide | |
| MXPA05011249A (es) | Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. | |
| GB0208129D0 (en) | Method of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: PANOS THERAPEUTICS LIMITED |
|
| HC | Change of company name or juridical status |
Owner name: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED |
|
| FA | Abandonment or withdrawal |